Day: January 27, 2025

PetVivo Board Appoints Eldred as Executive Director to Lead Company Product Commercialization and Operations MINNEAPOLIS, MN, Jan. 27, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQB: PETV, PETVW), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Mike Eldred as the Company’s Commercialization and Operations Advisor. His appointment as an Executive Director by the Company’s Board of Directors draws upon Mr. Eldred’s 30 years of executive experience in animal health and the veterinary industry to ramp up its product development and sales efforts. For the past 20 years, Mr. Eldred served as President of North American Operations for Dechra Pharmaceutical, a global specialist in veterinary pharmaceuticals. He built Dechra’s North American subsidiary from the ‘ground up’ to become...

Disguise Announces Exclusive Global Rights for A Minecraft MovieDisguise Announces Exclusive Global Rights for the Hugely Anticipated Big Screen Adventure “A Minecraft Movie”POWAY, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) — Disguise, Inc., the costume division of leading toy and consumer products company JAKKS Pacific, Inc. (NASDAQ: JAKK), has proudly announced global licensing rights to design, produce, and market costumes inspired by A MINECRAFT MOVIE. This major announcement solidifies Disguise’s long-standing partnership with the Minecraft brand, the world’s most popular video game, and extends their leadership in the gaming costume market. As the exclusive costume partner for Minecraft, Disguise continues to bring the iconic game’s characters and themes to life for fans around the world. The highly anticipated...

ROUYN-NORANDA, Quebec, Jan. 27, 2025 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to inform shareholders that Brunswick Exploration Inc. (BRW-TSXV, BRWXF-OTCQB, 1XQ-FRA) has started a 5,000-metre drill program on Globex’s Lac Escale (Mirage) royalty property in the Eeyou-Istchee-James Bay region of Quebec. Globex retains a 3% Gross Metal Royalty on the Lac Escale claims and within a 1-kilometer area of influence around the claim’s external boundaries as well as a $100,000 per year advance royalty starting at the fifth year of the agreement. Drilling will focus on several untested targets east...

ANCHORAGE, Alaska, Jan. 27, 2025 (GLOBE NEWSWIRE) — Northrim BanCorp, Inc. (NASDAQ: NRIM) today announced that the Board of Directors declared a regular quarterly cash dividend of $0.64 per share. The dividend will be payable on March 14, 2025, to shareholders of record at the close of business on March 6, 2025. “We are pleased to announce a quarterly dividend of $0.64 per share, as we continue to provide returns to our shareholders,” said Mike Huston, President and CEO. At the stock price of $78.80 per share at the close of the market on January 23, 2025, the current dividend equates to a yield of 3.25% on an annualized basis. On January 24, 2025, Northrim reported net income of $10.9 million, or $1.95 per diluted share, in the fourth quarter of 2024, compared to $8.8 million, or $1.57 per diluted share, in the third quarter of...

Latest donation brings total contribution to more than $170 million SUNNYVALE, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) — Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced a $45 million gift to the Intuitive Foundation that will be used to support the Foundation’s mission of reducing the global burden of disease and suffering through philanthropy, research, and education aimed at better outcomes for patients everywhere. This latest donation brings the contributions made by Intuitive to the Foundation to more than $170 million since it was founded in 2018. “We are pleased to support the important work that the Intuitive Foundation undertakes in providing health and medical fellowships and grants worldwide, and programs that support STEM and other research...

VIENNA, Va, Jan. 27, 2025 (GLOBE NEWSWIRE) — Urgent.ly Inc. (Nasdaq: ULY) (“Urgently” or “the Company”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, announced today its board of directors has appointed Alex Zyngier to serve as a member of the board, effective January 23, 2025. “Alex is a seasoned leader with a proven track record of navigating complex business challenges and driving growth,” said Matt Booth, Chief Executive Officer and President of Urgently. “With over 30 years of investment, strategy, governance and operating experience across a range of industries, Alex brings a wealth of expertise to Urgently as the Company continues to transform the roadside assistance industry. We are thrilled to welcome him to our board and look forward to his contributions.” “I am honored...

Sneak Peek Unveiled Last Night at Sundance Film Festival Available to Watch Now on YouTube, X, Instagram and LinkedIn BEVERLY HILLS, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) — Kartoon Studios (NYSE American: TOON) today publicly unveiled the trailer for its highly anticipated animated production, The Hundred Acre Wood’s Winnie-the-Pooh. Available now on Kartoon Studios’ X, Instagram, LinkedIn, and YouTube accounts, the trailer offers audiences a first look at the company’s most ambitious production in its history, coming at the end of this year. The trailer was revealed in a ‘Sneak Peak’ last night at the Sundance Film Festival at a special event held by Harbor Fund. Based on one of the most successful and beloved children’s properties of all time, The Hundred Acre Wood’s Winnie-the-Pooh represents Kartoon Studios’ largest production...

– High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of Alpha DaRT® – – Ad-hoc analyses of pancreatic cancer population subgroups suggest meaningful improvement in median overall survival (OS) for patients treated with Alpha DaRT after prior therapy, compared to previously published studies of alternative monotherapies, across all analyzed subgroups – – Investigational Device Exemption (IDE) received from the FDA to conduct a U.S. pilot study of Alpha DaRT together with first-line chemotherapy in patients with metastatic pancreatic cancer – – Approval received from France’s Ministry of Health to commence French multicenter clinical trial of Alpha DaRT alongside capecitabine for patients with locally advanced pancreatic...